LeBlanc R, Hollmann S, Tay J. CANADIAN COST ANALYSIS COMPARING MAINTENANCE THERAPY WITH BORTEZOMIB VERSUS LENALIDOMIDE FOR PATIENTS WITH MULTIPLE MYELOMA POST AUTOLOGOUS STEM CELL TRANSPLANT. J Popl Ther Clin Pharmacol. 2018;23(1). Accessed October 11, 2025. https://jptcp.com/index.php/jptcp/article/view/237